Ironwood Pharmaceuticals (IRWD) Cash from Operations Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 425.00% |
| 10 | Ironwood Pharmaceuticals | 639.91 Mn | 419.44 Mn | - | -74.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.34% |
| Dec 31, 2025 | 390.17% |
| Sep 30, 2025 | 381.37% |
| Jun 30, 2025 | -145.03% |
| Mar 31, 2025 | -55.64% |
| Dec 31, 2024 | -57.54% |
| Sep 30, 2024 | -69.55% |
| Jun 30, 2024 | -4.28% |
| Mar 31, 2024 | -43.89% |
| Dec 31, 2023 | -54.74% |
| Sep 30, 2023 | -53.02% |
| Jun 30, 2023 | -43.02% |
| Mar 31, 2023 | 25.02% |
| Dec 31, 2022 | 22.63% |
| Sep 30, 2022 | -7.96% |
| Jun 30, 2022 | 26.35% |
| Mar 31, 2022 | -12.99% |
| Dec 31, 2021 | 25.34% |
| Sep 30, 2021 | 39.96% |
| Jun 30, 2021 | 141.78% |